Details
Product Name in the RMS: TADOGLEN 50/37.5/200 mg
MR Number: CZ/H/0743/003
Date of outcome: 17.01.2015
Type of application | |
---|---|
Level 1: Level 2: Level 3: Level 4: Level 5: |
Abridged Additional Strength/Form Generic Chemical Substance Prescription Only |
Active Substances |
carbidopa monohydrate 37,5 mg entacapone 200 mg levodopa 150 mg |
Form | Film coated tablet |
MA Holder in the RMS |
Change RMS FI/H/831 Glenmark Pharmaceuticals s.r.o. Hvězdova 1716/2b 14074 Praha 4 Czech Republic |
RMS | Czech Republic |
Date of last change | 23.10.2020 |
ATC-Code |
N04BA03 Levodopa, decarboxylase inhibitor and COMT inhibitor |
CMS Country | Domestic Product Name |
---|---|
Romania | Tadoglen |
Slovak Republic |
Documents | |
---|---|
FinalSPC: | CZ_H_0743_003_FinalSPC.pdf (28.11.2019) |
FinalPL: | CZ_H_0743_003_FinalPL.pdf (28.11.2019) |
Finalised Product Information: | CZ_H_0743_003_FinalPI.pdf (06.06.2018) |